Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-251013
Filing Date
2024-11-05
Accepted
2024-11-05 09:15:27
Documents
4
Period of Report
2024-12-19

Document Format Files

Seq Description Document Type Size
1 PRE 14A d852912dpre14a.htm PRE 14A 227979
2 GRAPHIC g852912dsp026.jpg GRAPHIC 126405
3 GRAPHIC g852912dsp027.jpg GRAPHIC 125731
4 GRAPHIC g852912g53p02.jpg GRAPHIC 35870
  Complete submission text file 0001193125-24-251013.txt   612365
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39244 | Film No.: 241425955
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)